Ex vivo lung perfusion (EVLP) is a rapidly developing and increasingly utilized technology to increase the lung donor pool for transplantation.

EVLP has evolved into a device for logistical optimization of the lung transplant process and increases the tolerability of cold ischemic time through its use.

Monitoring of the lung(s) on EVLP allows for more thorough evaluation of the lung(s) and increases confidence in donor lung utilization.

Issues such as atelectasis and pulmonary edema may be improved through the use of EVLP. Future opportunities for treatment of donor lung infection and immunomodulation exist on the EVLP platform.

Rapid and more universal adoption of EVLP remains limited by resource utilization.